Literature DB >> 2581599

Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.

E G Shephard, L Malan, C M Macfarlane, W Mouton, J R Joubert.   

Abstract

The effect of specific antigen challenge on the lung function of eight allergic asthmatic patients after placebo and indomethacin pretreatment has been investigated. Plasma levels of thromboxane B2(TxB2), metabolite of thromboxane A2, 6-keto-PGF1 alpha, metabolite of epoprostenol, (prostacyclin, PGI2) and beta-thromboglobulin (beta TBG) following antigen challenge in these eight patients have also been measured after placebo and indomethacin pretreatment. Each patient underwent two antigen inhalations 1 week apart. One challenge took place after 4 days pretreatment with indomethacin capsules 25 mg four times daily, and the other took place following 4 days placebo pretreatment, one matched capsule four times daily. The order of administration was random but balanced and blind with respect to the patient. Following placebo pretreatment two patients presented with an early antigen response only, four presented with a biphasic antigen response and two presented with a delayed antigen response only. The asthmatic response for each patient was consistent on re-exposure. Indomethacin pretreatment suppressed the delayed antigen induced asthmatic response. This suppression was reproducible. There was a rise in plasma TxB2 levels on antigen challenge following placebo pretreatment but not following indomethacin pretreatment, whereas there was a rise in 6-keto-PGF1 alpha after antigen challenge following indomethacin but not placebo pretreatment. No significant change in plasma beta TBG or platelet counts from control values was observed following antigen challenge with either placebo or indomethacin pretreatment. It is suggested that the production of PGI2 and suppression of TxA2 by indomethacin pretreatment contribute to the suppression of the delayed antigen induced asthmatic response and that platelets play a minimal role in this process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581599      PMCID: PMC1463826          DOI: 10.1111/j.1365-2125.1985.tb02671.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Thromboxane A2: effects on airway and vascular smooth muscle.

Authors:  J Svenssen; K Strandberg; T Tuvemo; M Hamberg
Journal:  Prostaglandins       Date:  1977-09

2.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides.

Authors:  P Needleman; S Moncada; S Bunting; J R Vane; M Hamberg; B Samuelsson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

3.  Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease.

Authors:  K F Austen; R P Orange
Journal:  Am Rev Respir Dis       Date:  1975-09

4.  Prostaglandins and smooth muscle.

Authors:  E W Horton
Journal:  Br Med Bull       Date:  1979-09       Impact factor: 4.291

5.  Analogue device for measurement of area under the maximum expiratory flow-volume curve.

Authors:  A E Bunn; H M De Brandt; J C Vermaak
Journal:  Med Biol Eng Comput       Date:  1979-09       Impact factor: 2.602

Review 6.  Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells.

Authors:  G Weissmann; J E Smolen; H Korchak
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

7.  Increased plasma levels of 15-keto-13,14-dihydro-prostaglandin F2X after allergen-provoked asthma in man.

Authors:  K Gréen; P Hedqvist; N Svanborg
Journal:  Lancet       Date:  1974-12-14       Impact factor: 79.321

8.  Specific receptors for prostaglandins in airways.

Authors:  P J Gardiner; H O Collier
Journal:  Prostaglandins       Date:  1980-06

9.  Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.

Authors:  R P Schleimer; E S Schulman; D W MacGlashan; S P Peters; E C Hayes; G K Adams; L M Lichtenstein; N F Adkinson
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  The differential inhibition of prostaglandin synthesis in platelets and vascular tissue in response to aspirin.

Authors:  B S Shaikh; S J Bott; L M Demers
Journal:  Prostaglandins Med       Date:  1980-06
View more
  11 in total

Review 1.  Could NSAIDs have a role as antiasthmatic agents?

Authors:  S Bianco; M G Pieroni; R M Refini; M Robuschi; A Vaghi; P Sestini
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

2.  Oral nafazatrom in man: effect on inhaled antigen challenge.

Authors:  R W Fuller; N Maltby; R Richmond; C T Dollery; G W Taylor; W Ritter; E Philipp
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  The role of prostaglandins in allergic lung inflammation and asthma.

Authors:  Dru Claar; Tina V Hartert; Ray Stokes Peebles
Journal:  Expert Rev Respir Med       Date:  2014-12-26       Impact factor: 3.772

4.  Effects of a 5-lipoxygenase inhibitor (L-651,392) on primary and late pulmonary responses to ascaris antigen in the squirrel monkey.

Authors:  C S McFarlane; R Hamel; A W Ford-Hutchinson
Journal:  Agents Actions       Date:  1987-10

5.  BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.

Authors:  H P Francis; S J Greenham; U P Patel; A M Thompson; P J Gardiner
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

6.  Nimesulide does not interfere with airway responsiveness in allergic asthma.

Authors:  V Brusasco; E Crimi; I Scaricabarozzi
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.

Authors:  S L Johnston; P G Bardin; J Harrison; W Ritter; J R Joubert; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 8.  Prostaglandins in asthma and allergic diseases.

Authors:  R Stokes Peebles
Journal:  Pharmacol Ther       Date:  2018-08-03       Impact factor: 12.310

9.  Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.

Authors:  N Curzen; P Rafferty; S T Holgate
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

Review 10.  Leukotriene and thromboxane antagonists.

Authors:  T Obata; N Yamashita; T Nakagawa
Journal:  Clin Rev Allergy       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.